Stocks / AMEX / Regentis Biomaterials Ltd.

Regentis Biomaterials Ltd.

Industry: Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol: RGNT – AMEX

Animal Usage: Animal Testing

Our Opinion

Regentis Biomaterials Ltd. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following press release that they use animals for drug testing.

“The same logic points beyond focal defects. Regentis has described earlier-stage formulations built on the Gelrin platform, including a GelrinP paste form for smaller joints such as the ankle, wrist, and elbow, and injectable thermo-responsive gel targeted at moderate osteoarthritis. Both remain preclinical, supported by animal studies.” Read the following article

Company Description

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Company Website: https://www.regentis.co.il

Contact: egeller@medicavp.com